Le Lézard
Classified in: Health

Renowned Specialist Laura Rhodes-Levin, LMFT., Founder of The Missing Peace Center for Anxiety, Expands Facility and Opens The Missing Peace Center for the Brain


AGOURA HILLS, Calif., July 19, 2019 /PRNewswire-PRWeb/ -- Today, Licensed Therapist and Founder/Operator of The Missing Peace Center for Anxiety, Laura Rhodes Levin, L.M.F.T., is proud to announce the expansion of The Missing Peace with the opening of their newest facility, The Missing Peace Center for the Brain. The Center for the Brain opens its doors July 19, 2019.

The Missing Peace Center for the Brain exclusively offers Neurofeedback as the sole treatment to target ADHD and ADD, stress disorders, anxiety, panic attacks, addiction, Asperger's, depression, migraines, as well as select forms of memory concerns, and sleep issues.

"I am thrilled to expand my facility and officially open The Missing Peace Center for the Brain." Says Founder and Operator, Laura Rhodes Levin, LMFT. "We wanted to offer patients a facility that focuses solely on Neurofeedback. This way, we can pinpoint the areas of the brain associated with these debilitating ailments and exponentially accelerate the treatment process."

Neurofeedback, also called neurotherapy or neurobiofeedback, is a type of biofeedback that uses real-time displays of brain activity?most commonly electroencephalography ?in an attempt to teach self-regulation of brain function. This particular modality of treatment has been used by Tom Brady, Tony Robbins, Yolanda Foster and a long list of celebrity and high profile individuals.

"In a nutshell, Neurofeedback is your brain's ability to look at itself in the mirror so it can begin to self-repair. As soon as your brain is able to see itself, it will know exactly what to do and will begin the process of healing." Says Rhodes-Levin.

"I suffered from severe anxiety from the time that I was a little girl and always thought I was just wired that way. The game really changed for me when I tried Neurofeedback. Neurofeedback changed my life and I am lucky to watch it change the lives of the countless individuals I have worked with". Says Rhodes-Levin.

About Laura Rhodes-Levin:
Laura Rhodes-Levin, LMFT., is a licensed therapist who specializes in the evaluation and treatment of anxiety, depression, and trauma. Laura holds a Master of Science in Counseling and is known for her unique approach in the understanding of anxiety and anxiety disorders.

She is the Founder of The Missing Peace Center for Anxiety, a facility that offers a variety of modalities, including Psychotherapy, Neurofeedback, Meditation and Mindfulness, to help ease the nervous system and restore the brain, body, and mind to a place of calmness and relaxation.

Laura has received many honors for her work including a Recognition Award for Going Above and Beyond in the Assistance of Rehabilitation Programs for the National Council of Jewish Women, and The National Council of Jewish Women has bestowed her with the Unsung Hero Award by the City of West Hollywood, as well.

In addition, she serves as the Co-Chair for the Special Interest Group of Integrative health for the Anxiety and Depression Association of America (ADAA), an international nonprofit membership organization and leader in the education, training, and research for anxiety, depression and related disorders.

 

SOURCE Laura Rhodes-Levin


These press releases may also interest you

at 04:00
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...

at 04:00
TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and...

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...



News published on and distributed by: